Moreover it has been found that certain SNPs of PD-L1 are associated with NSCLC outcome [24], whereas other data suggest that some SNPs of PD-L1 have clinical value in gastric adenocarcinoma [25] and NSCLC [26]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.